Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SS Pharmaceuticals, commonly branded as SS Pharma, is an India-based pharmaceutical manufacturing company focused on small-molecule active pharmaceutical ingredients, registered intermediates, key starting materials, pyridine derivatives, and integrated CRDMO/CDMO services. The company markets itself as a science-driven partner supporting customers from route scouting and process development through scale-up and commercial manufacturing. Its capabilities emphasize process chemistry, analytical development, regulatory support, DMF-related documentation, and cGMP-compliant manufacturing for regulated and semi-regulated markets. SS Pharma appears to operate corporate and manufacturing facilities in Hyderabad and Visakhapatnam, India, with a U.S. office in New Jersey. Rather than a classic therapeutic biotech with proprietary clinical assets, it is best characterized as a commercial pharma manufacturing and services organization supplying APIs and intermediates across cardiometabolic, CNS, inflammation, anti-infective, and oncology-related markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SS Pharmaceuticals.